The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

A METHOD OF EVALUATING A THERAPEUTIC AGENT

Results in a Study of Dibenamine
Published Online:https://doi.org/10.1176/ajp.107.6.463

1. A method of evaluating a therapeutic agent in psychiatric disorders is described. [see Tabel 1 in source pdf]

2. Advantages and disadvantages of such a method are discussed.

3. This method is used in a study of the effects of dibenamine in 30 patients suffering from various psychiatric disorders.

4. It is demonstrated that in the dosage used dibenamine is not more effective than a placebo in the care of patients as described.

5. Nausea and vomiting occurred in 11 of 30 patients receiving dibenamine, as against 2 receiving placebo.

6. An increase of symptoms was found in 3 of 5 depressed patients receiving dibenamine.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.